ArticleGynecologic oncology reports2026
A phase I dose-escalation study of Lobaplatin combined with paclitaxel in platinum-sensitive recurrent ovarian epithelial carcinoma: preliminary safety and tolerability supporting clinical trial dosing.
Dongling Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.